tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MYNZ Stock Latest News

Mainz Biomed receives Swiss regulatory approval to market ColoAlert
The FlyMainz Biomed receives Swiss regulatory approval to market ColoAlert
4d ago
MYNZ
Mainz Biomed Secures $3 Million Through Securities Purchase Agreement
PremiumCompany Announcements
Mainz Biomed Secures $3 Million Through Securities Purchase Agreement
12d ago
6K
MYNZ
Mainz Biomed files to sell 1.47M ordinary units
PremiumThe Fly
Mainz Biomed files to sell 1.47M ordinary units
18d ago
MYNZ
Mainz Biomed, CARE announce collaboration agreement
PremiumThe Fly
Mainz Biomed, CARE announce collaboration agreement
25d ago
MYNZ
Mainz Biomed reviews accomplishments for first half of 2025
PremiumThe Fly
Mainz Biomed reviews accomplishments for first half of 2025
1M ago
MYNZ
Mainz Biomed secures public funding to advance pancreatic cancer screening test
PremiumThe FlyMainz Biomed secures public funding to advance pancreatic cancer screening test
2M ago
MYNZ
Promising Advancements in Cancer Diagnostics Propel Mainz Biomed B.V. to a Buy Rating
Premium
Ratings
Promising Advancements in Cancer Diagnostics Propel Mainz Biomed B.V. to a Buy Rating
2M ago
MYNZ
Mainz initiates feasibility study of biomarker panel in PancAlert project
Premium
The Fly
Mainz initiates feasibility study of biomarker panel in PancAlert project
2M ago
MYNZ
Mainz Biomed N.V. Shareholders Approve Key Proposals at Annual Meeting
PremiumCompany Announcements
Mainz Biomed N.V. Shareholders Approve Key Proposals at Annual Meeting
2M ago
6K
MYNZ
Mainz Biomed N.V. Secures $4 Million Through Securities Offering
PremiumCompany Announcements
Mainz Biomed N.V. Secures $4 Million Through Securities Offering
3M ago
6K
MYNZ
Mainz Biomed prices $4.0M offering of common stock at $2.00 per unit
PremiumThe Fly
Mainz Biomed prices $4.0M offering of common stock at $2.00 per unit
3M ago
MYNZ
Mainz Biomed announces interim read out for eAArly DETECT 2 study
PremiumThe Fly
Mainz Biomed announces interim read out for eAArly DETECT 2 study
3M ago
MYNZ
Mainz Biomed files to sell 2.45M ordinary units
PremiumThe FlyMainz Biomed files to sell 2.45M ordinary units
3M ago
MYNZ
Mainz Biomed Prepares for June 2025 Annual General Meeting
Premium
Company Announcements
Mainz Biomed Prepares for June 2025 Annual General Meeting
4M ago
6K
MYNZ
Mainz Biomed enters partnership with EDX Medical Group
Premium
The Fly
Mainz Biomed enters partnership with EDX Medical Group
4M ago
MYNZ
Mainz Biomed provides Q1 update, path to FDA premarket approval
PremiumThe Fly
Mainz Biomed provides Q1 update, path to FDA premarket approval
4M ago
MYNZ
Mainz Biomed Reports 2024 Financial Success and Strategic Advances
PremiumCompany Announcements
Mainz Biomed Reports 2024 Financial Success and Strategic Advances
5M ago
6K
MYNZ
Mainz Biomed reports FY24 EPS ($22.36) vs ($64.76) last year
PremiumThe Fly
Mainz Biomed reports FY24 EPS ($22.36) vs ($64.76) last year
5M ago
MYNZ
Buy Rating for Mainz Biomed B.V. Driven by Promising CRC Screening Advancements and Strategic Partnerships
PremiumRatings
Buy Rating for Mainz Biomed B.V. Driven by Promising CRC Screening Advancements and Strategic Partnerships
5M ago
MYNZ
Mainz Biomed enrolls first patient in its eAArly DETECT 2 study
PremiumThe FlyMainz Biomed enrolls first patient in its eAArly DETECT 2 study
5M ago
MYNZ
Strategic Collaboration and Innovative Biomarkers Drive Buy Rating for Mainz Biomed
Premium
Ratings
Strategic Collaboration and Innovative Biomarkers Drive Buy Rating for Mainz Biomed
5M ago
MYNZ
Mainz Biomed’s Breakthrough in Pancreatic Cancer Detection
Premium
Company Announcements
Mainz Biomed’s Breakthrough in Pancreatic Cancer Detection
5M ago
6K
MYNZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >